Cargando…
Optimized and Personalized Phlebotomy Schedules for Patients Suffering From Polycythemia Vera
Polycythemia vera (PV) is a slow-growing type of blood cancer, where the production of red blood cells (RBCs) increase considerably. The principal treatment for targeting the symptoms of PV is bloodletting (phlebotomy) at regular intervals based on data derived from blood counts and physician assess...
Autores principales: | Lilienthal, Patrick, Tetschke, Manuel, Schalk, Enrico, Fischer, Thomas, Sager, Sebastian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180210/ https://www.ncbi.nlm.nih.gov/pubmed/32362837 http://dx.doi.org/10.3389/fphys.2020.00328 |
Ejemplares similares
-
The development of polycythemia vera after phlebotomy treatment for hereditary haemochromatosis
por: van Bommel, Erik JM, et al.
Publicado: (2021) -
Indications and use of therapeutic phlebotomy in polycythemia vera: which role for erythrocytapheresis?
por: Teofili, Luciana, et al.
Publicado: (2018) -
Different effect of hydroxyurea and phlebotomy on prevention of arterial and venous thrombosis in Polycythemia Vera
por: Barbui, Tiziano, et al.
Publicado: (2018) -
Low-risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera
por: Triguero, Ana, et al.
Publicado: (2022) -
Incidence of solid tumors in polycythemia vera treated with phlebotomy with or without hydroxyurea: ECLAP follow-up data
por: Ghirardi, Arianna, et al.
Publicado: (2018)